Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To describe a case of persistent placoid maculopathy (PPM) associated with juxtafoveal choroidal neovascularization (CNV) treated with intravitreal bevacizumab injection (IVBI). Design: Interventional case report. Methods: A 60-year-old patient referred for sudden vision loss was diagnosed with PPM complicated by a disciform scar in the right eye and juxtafoveal CNV in the left eye, undergoing 2 IVBIs. Results: Best-corrected visual acuity passed from 20/32 to 20/20 after 2 IVBIs, with complete resolution of intraretinal and subretinal fluid and disappearance of fluorescein leakage. Conclusions: IVBI is a promising treatment option for juxtafoveal CNV secondary to PPM.

Original languageEnglish
Pages (from-to)399-401
Number of pages3
JournalOcular Immunology and Inflammation
Volume18
Issue number5
DOIs
Publication statusPublished - Oct 2010

Keywords

  • Choroidal neovascularization
  • Intravitreal bevacizumab injection
  • Persistent placoid maculopathy

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab'. Together they form a unique fingerprint.

Cite this